European Urology Oncology

Slides:



Advertisements
Similar presentations
Volume 68, Issue 6, Pages (December 2015)
Advertisements

European Urology Focus
Volume 62, Issue 4, Pages (October 2012)
Volume 66, Issue 6, Pages (December 2014)
European Urology Oncology
European Urology Oncology
Volume 50, Issue 5, Pages (November 2006)
Volume 68, Issue 3, Pages (September 2015)
Volume 51, Issue 4, Pages (April 2007)
Volume 51, Issue 3, Pages (March 2007)
Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S
European Urology Oncology
European Urology Oncology
European Urology Oncology
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 73, Issue 2, Pages (February 2018)
Volume 73, Issue 3, Pages (March 2018)
European Urology Oncology
European Urology Oncology
Volume 65, Issue 2, Pages (February 2014)
Stephen B. Williams, Ashish M
Validation of Preoperative Nomograms Predicting Lymph Node Involvement in Prostate Cancer: A Bi-institutional Study  Alexander I. Hinev, Vesselin I. Hadjiev,
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
Volume 71, Issue 4, Pages (April 2017)
Volume 60, Issue 6, Pages (December 2011)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
European Urology Oncology
European Urology Oncology
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
European Urology Oncology
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA  Nawar Hanna, Quoc-Dien Trinh,
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Volume 74, Issue 4, Pages (October 2018)
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
European Urology Oncology
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study  Andrew M. Erickson, Stefano Luzzago, Axel.
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas.
European Urology Oncology
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis  Joseph Sargon Joseph, Vincent.
The Cost to Medicare of Bladder Cancer Care
European Urology Oncology
European Urology Oncology
Axel Heidenreich  European Urology Supplements 
Economic Burden of Bladder Cancer Across the European Union
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
European Urology Oncology
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
European Urology Oncology
Axel Heidenreich  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
European Urology Oncology
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Presentation transcript:

European Urology Oncology Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?  Alexander P. Cole, Ashwin Ramaswamy, Sabrina Harmouch, Sean A. Fletcher, Philipp Gild, Maxine Sun, Stuart R. Lipsitz, H. Abraham Chiang, Adil H. Haider, Mark A. Preston, Adam S. Kibel, Quoc-Dien Trinh  European Urology Oncology  DOI: 10.1016/j.euo.2018.08.027 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Post-cystectomy 30-d readmission rates at 320 US hospitals (unadjusted) with 95% confidence intervals. RC=radical cystectomy. European Urology Oncology DOI: (10.1016/j.euo.2018.08.027) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Estimated probability of 30-d readmission at 320 US hospitals on the basis of facility random intercepts only (holding patient characteristics constant at the population mean). The grey lines denote the 95% confidence interval. European Urology Oncology DOI: (10.1016/j.euo.2018.08.027) Copyright © 2018 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.